The estimated Net Worth of Nooshin Hussainy is at least $45.3 millier dollars as of 6 August 2019. Ms. Hussainy owns over 5,000 units of Obalon Therapeutics Inc stock worth over $45,262 and over the last 8 years she sold OBLN stock worth over $0. In addition, she makes $0 as Chief Financial Officer at Obalon Therapeutics Inc.
Nooshin has made over 1 trades of the Obalon Therapeutics Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently she bought 5,000 units of OBLN stock worth $20,000 on 6 August 2019.
The largest trade she's ever made was buying 5,000 units of Obalon Therapeutics Inc stock on 6 August 2019 worth over $20,000. On average, Nooshin trades about 455 units every 0 days since 2016. As of 6 August 2019 she still owns at least 16,340 units of Obalon Therapeutics Inc stock.
You can see the complete history of Ms. Hussainy stock trades at the bottom of the page.
Nooshin Hussainy has been appointed as Chief Financial Officer of the Company effective 10/24/2020. Prior to joining us, Ms. Hussainy served as the Vice President of Accounting and Corporate Controller at GenMark Diagnostics, Inc., a molecular diagnostics company, from April 2010 to September 2011. Prior to GenMark Diagnostics, Ms. Hussainy served as the Vice President of Accounting and Corporate Controller at ACTIVE Network, LLC, a worldwide registration software and advertising company, from 2008 to 2010. Ms. Hussainy previously served as the Corporate Controller at DexCom from 2003 to 2008 and at Entropia, Inc. from 2001 to 2003. Ms. Hussainy has also served as the Assistant Controller at Thermolase Corporation. Ms. Hussainy holds a B.A. from National University.
Nooshin Hussainy is 58, she's been the Chief Financial Officer of Obalon Therapeutics Inc since 2020. There are 7 older and 5 younger executives at Obalon Therapeutics Inc. The oldest executive at Obalon Therapeutics Inc is Raymond Dittamore, 73, who is the Independent Director.
Nooshin's mailing address filed with the SEC is C/O OBALON THERAPEUTICS, INC., 5421 AVENIDA ENCINAS, SUITE F, CARLSBAD, CA, 92008.
Over the last 8 years, insiders at Obalon Therapeutics Inc have traded over $0 worth of Obalon Therapeutics Inc stock and bought 3,260,355 units worth $6,939,913 . The most active insiders traders include Parters Vii L Pblair James ..., Partners X Lp Inter West Ma... et David Moatazedi. On average, Obalon Therapeutics Inc executives and independent directors trade stock every 54 days with the average trade being worth of $432,771. The most recent stock trade was executed by William J. Plovanic on 12 November 2019, trading 65,000 units of OBLN stock currently worth $107,900.
Obalon Therapeutics, Inc. is a San Diego-based company focused on developing and commercializing novel technologies for weight loss.
Obalon Therapeutics Inc executives and other stock owners filed with the SEC include: